OA11867A - Novel pharmaceutical. - Google Patents

Novel pharmaceutical. Download PDF

Info

Publication number
OA11867A
OA11867A OA1200100269A OA1200100269A OA11867A OA 11867 A OA11867 A OA 11867A OA 1200100269 A OA1200100269 A OA 1200100269A OA 1200100269 A OA1200100269 A OA 1200100269A OA 11867 A OA11867 A OA 11867A
Authority
OA
OAPI
Prior art keywords
hydrate
hydrate according
hydrochloride
compound
methyl
Prior art date
Application number
OA1200100269A
Other languages
English (en)
Inventor
Paul David James Blackler
Andrew Simon Craig
Robert Gordon Giles
Michael John Sasse
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of OA11867A publication Critical patent/OA11867A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
OA1200100269A 1999-04-20 2000-04-19 Novel pharmaceutical. OA11867A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9909075.5A GB9909075D0 (en) 1999-04-20 1999-04-20 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
OA11867A true OA11867A (en) 2006-03-02

Family

ID=10851922

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200100269A OA11867A (en) 1999-04-20 2000-04-19 Novel pharmaceutical.

Country Status (42)

Country Link
EP (2) EP1173437B1 (fr)
JP (2) JP4283450B2 (fr)
KR (1) KR100677815B1 (fr)
CN (2) CN1327446A (fr)
AP (1) AP1680A (fr)
AR (2) AR023563A1 (fr)
AT (1) ATE262524T1 (fr)
AU (1) AU773112B2 (fr)
BG (1) BG65428B1 (fr)
BR (1) BR0009898A (fr)
CA (1) CA2370270A1 (fr)
CO (1) CO5170420A1 (fr)
CZ (1) CZ300934B6 (fr)
DE (1) DE60009276T2 (fr)
DK (1) DK1173437T3 (fr)
DZ (1) DZ3163A1 (fr)
EA (1) EA004769B1 (fr)
EG (1) EG23946A (fr)
ES (1) ES2214267T3 (fr)
GB (1) GB9909075D0 (fr)
HK (1) HK1045304B (fr)
HR (1) HRP20010771B1 (fr)
HU (1) HUP0200785A3 (fr)
IL (1) IL146077A0 (fr)
MA (1) MA26784A1 (fr)
MX (1) MXPA01010695A (fr)
MY (1) MY125209A (fr)
NO (1) NO320573B1 (fr)
NZ (1) NZ515164A (fr)
OA (1) OA11867A (fr)
PE (1) PE20010047A1 (fr)
PL (1) PL351115A1 (fr)
PT (1) PT1173437E (fr)
RS (1) RS50137B (fr)
SI (1) SI1173437T1 (fr)
SK (1) SK284990B6 (fr)
TR (1) TR200103041T2 (fr)
TW (1) TWI291463B (fr)
UA (1) UA72245C2 (fr)
UY (1) UY26113A1 (fr)
WO (1) WO2000063206A2 (fr)
ZA (1) ZA200108721B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9909075D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
CN100390170C (zh) * 2001-11-21 2008-05-28 史密斯克莱·比奇曼公司 5－(4－(2－(n－甲基－n－(2－吡啶基)氨基)乙氧基)苄基)噻唑烷－2,4－二酮苯磺酸盐，它的制备方法,其多晶型物ⅰ、ⅱ和ⅲ和它作为药物活性成分的用途
KR100450700B1 (ko) * 2002-03-22 2004-10-01 주식회사종근당 티아졸리딘디온 유도체 화합물 및 이를 함유하는 약제학적조성물
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
EP1842850A1 (fr) * 2006-03-23 2007-10-10 Sandoz AG Rosiglitazone hydrochlorid hemihydrat

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856378T2 (de) * 1987-09-04 2000-05-11 Beecham Group Plc Substituierte Thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9909075D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
PT1173437E (pt) 2004-06-30
MA26784A1 (fr) 2004-12-20
JP2009161544A (ja) 2009-07-23
SK14892001A3 (sk) 2002-02-05
KR20010112446A (ko) 2001-12-20
CZ300934B6 (cs) 2009-09-16
DE60009276D1 (de) 2004-04-29
CA2370270A1 (fr) 2000-10-26
ZA200108721B (en) 2002-09-13
NO20015105L (no) 2001-12-19
JP2002542243A (ja) 2002-12-10
BG65428B1 (bg) 2008-07-31
HK1045304A1 (en) 2002-11-22
NZ515164A (en) 2004-02-27
AP2001002332A0 (en) 2001-12-31
MY125209A (en) 2006-07-31
PL351115A1 (en) 2003-03-24
WO2000063206A3 (fr) 2001-02-22
CN1327446A (zh) 2001-12-19
ATE262524T1 (de) 2004-04-15
ES2214267T3 (es) 2004-09-16
CZ20013758A3 (cs) 2003-05-14
UY26113A1 (es) 2000-12-29
CO5170420A1 (es) 2002-06-27
HUP0200785A3 (en) 2004-03-29
YU81601A (sh) 2004-09-03
AU773112B2 (en) 2004-05-20
HUP0200785A2 (en) 2002-08-28
EP1411054A1 (fr) 2004-04-21
UA72245C2 (uk) 2005-02-15
SK284990B6 (sk) 2006-04-06
GB9909075D0 (en) 1999-06-16
SI1173437T1 (en) 2004-06-30
AR023567A1 (es) 2002-09-04
NO20015105D0 (no) 2001-10-19
AP1680A (en) 2006-11-27
AR023563A1 (es) 2002-09-04
PE20010047A1 (es) 2001-03-10
MXPA01010695A (es) 2002-06-04
EA004769B1 (ru) 2004-08-26
RS50137B (sr) 2009-03-25
BG106120A (en) 2002-05-31
WO2000063206A2 (fr) 2000-10-26
DE60009276T2 (de) 2004-08-26
HRP20010771B1 (en) 2005-06-30
BR0009898A (pt) 2002-04-16
KR100677815B1 (ko) 2007-02-05
DK1173437T3 (da) 2004-07-12
DZ3163A1 (fr) 2000-10-26
NO320573B1 (no) 2005-12-27
EA200101102A1 (ru) 2002-04-25
JP4283450B2 (ja) 2009-06-24
TWI291463B (en) 2007-12-21
CN101125851A (zh) 2008-02-20
EP1173437B1 (fr) 2004-03-24
HRP20010771A2 (en) 2002-12-31
HK1045304B (zh) 2004-12-24
TR200103041T2 (tr) 2002-03-21
IL146077A0 (en) 2002-07-25
EP1173437A2 (fr) 2002-01-23
AU4131100A (en) 2000-11-02
EG23946A (en) 2008-01-22

Similar Documents

Publication Publication Date Title
US20060189659A1 (en) Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione maleic acid salt
US6815457B1 (en) Thiazolidinedione derivative and its use as antidiabetic
AU765005B2 (en) Polymorph of 5-(4-(2- (N-methyl-N-( 2-pyridyl)amino) ethoxy)benzyl) thiazolidine-2,4-dione, maleic acid salt
OA11873A (en) Novel pharmaceutical.
US6664278B2 (en) Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
EP1173436B1 (fr) Derive de thiazolidinedione et son utilisation comme antidiabetique
OA11867A (en) Novel pharmaceutical.
US7358366B2 (en) Thiazolidinedione derivative and its use as antidiabetic
OA12284A (en) Thiazolidinedione salt for treatment of diabetes mellitus.
OA12355A (en) Tartrate salts of thiazolidinedione derivative.
US20040038968A1 (en) Thiazolidinedione derivative and its use as antidiabetic
AU2754902A (en) Novel pharmaceutical
AU774613B2 (en) Hydrate of 5-(4-(2- (N-methyl-N- (2-pyridil)amino) ethoxy)benzyl) thiazolidine-2,4-dione maleic acid salt